Omega Healthcare Investors reported Q1 AFFO of $0.82 per share, exceeding the $0.48 consensus, and raised its 2026 AFFO guidance to a $3.22 midpoint, indicating strong performance and stability.
Samsung regained the title as the world's number one smartphone brand, thanks to 65.4 million shipments for the period, which represents an 8% rise compared to the same time last year. The Galaxy S26 series is seeing strong demand, and the recently launched Galaxy A37 and Galaxy A57 are also key contributors to Samsung's 22% market share.
BTIG sees Atlassian delivering another solid quarter of cloud growth, but not accelerating on an organic basis. That distinction matters because reported cloud growth has been flattered by acquisitions and migration tailwinds.
William Blair's bull thesis centers on Cameco's unique position across the entire nuclear fuel cycle. The company's 49% ownership stake in Westinghouse Electric Company is a key differentiator.
Barclays believes Maryland and Pennsylvania are becoming less constructive jurisdictions for Exelon, and that this should result in a wider discount on Exelon's distribution portfolio on most comparatives.
Citi's thesis rests on the 'humanization' of pets. The firm says the humanization pet trend is real and should drive more spending, a view supported by data showing nearly 40% of dogs of any age or size may be affected by OA pain and up to 40% of all cats have clinical signs of OA.
Goldman Sachs' Chief Equity Strategist Peter Oppenheimer has called the recent sell-off in U.S. tech stocks a rare 'buying opportunity,' suggesting that the current market conditions may favor investment in this sector.